Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

NCT04665037 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Fungal Infection

Interventions

DRUG: Posaconazole IV 6 mg/kg
DRUG: Posaconazole PFS 6 mg/kg

Sponsor

Merck Sharp & Dohme LLC